1
|
Clowes Candadai SV, Sikes MC, Thies JM, Freed AS, Bennett JT. Rapid clinical exome sequencing in a pediatric ICU: Genetic counselor impacts and challenges. J Genet Couns 2020; 28:283-291. [PMID: 30964580 DOI: 10.1002/jgc4.1116] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2018] [Revised: 02/17/2019] [Accepted: 02/20/2019] [Indexed: 01/02/2023]
Abstract
Exome sequencing (ES) has revolutionized molecular diagnosis in children with genetic disease over the past decade. However, exome sequencing in the inpatient setting has traditionally been discouraged, in part due to an increased risk of providers failing to retrieve and act upon results, as many patients are discharged before results return. The development of rapid turn-around-times (TATs) for genomic testing has begun to shift this paradigm. Rapid exome sequencing (rES) is increasingly being used as a diagnostic tool for critically ill infants with likely genetic disease and presents significant challenges to execute. We implemented a program, entitled the Rapid Inpatient Genomic Testing (RIGhT) project, to identify critically ill children for whom a molecular diagnosis is likely to change inpatient management. Two important goals of the RIGhT project were to provide appropriate genetic counseling, and to develop protocols to ensure efficient test coordination- both of which relied heavily on laboratory and clinic-based genetic counselors (GCs). Here, rES was performed on 27 inpatient trios from October 2016 to August 2018; laboratory and clinical GCs encountered significant challenges in the coordination of this testing. The GCs involved retrospectively reviewed these cases and identified three common challenges encountered during pretest counseling and coordination. The aim of this paper is to define these challenges using illustrative case examples that highlight the importance of including GCs to support rES programs.
Collapse
Affiliation(s)
- Sarah V Clowes Candadai
- Department of Laboratories, Seattle Children's Hospital, Seattle, Washington.,Patient-Centered Laboratory Utilization Guidance Services (PLUGS), Seattle Children's Hospital, Seattle, Washington
| | - Megan C Sikes
- Division of Genetic Medicine, Seattle Children's Hospital, Seattle, Washington
| | - Jenny M Thies
- Division of Genetic Medicine, Seattle Children's Hospital, Seattle, Washington
| | - Amanda S Freed
- Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, Washington
| | - James T Bennett
- Department of Laboratories, Seattle Children's Hospital, Seattle, Washington.,Division of Genetic Medicine, Seattle Children's Hospital, Seattle, Washington.,Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, Washington.,Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, Washington
| |
Collapse
|
2
|
Laurino MY, Leppig KA, Abad PJ, Cham B, Chu YWY, Kejriwal S, Lee JMH, Sternen DL, Thompson JK, Burgess MJ, Chien S, Elackatt N, Lim JY, Sura T, Faradz S, Padilla C, Paz ECDL, Nauphar D, Nguyen KN, Zayts O, Vu DC, Thong MK. A Report on Ten Asia Pacific Countries on Current Status and Future Directions of the Genetic Counseling Profession: The Establishment of the Professional Society of Genetic Counselors in Asia. J Genet Couns 2017; 27:21-32. [PMID: 28699126 DOI: 10.1007/s10897-017-0115-6] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2016] [Accepted: 05/23/2017] [Indexed: 11/26/2022]
Abstract
The Professional Society of Genetic Counselors in Asia (PSGCA) was recently established as a special interest group of the Asia Pacific Society of Human Genetics. Fostering partnerships across the globe, the PSGCA's vision is to be the lead organization that advances and mainstreams the genetic counseling profession in Asia and ensures individuals have access to genetic counseling services. Its mission is to promote quality genetic counseling services in the region by enhancing practice and curricular standards, research and continuing education. The PSGCA was formally launched during the Genetic Counseling Pre-Conference Workshop held at the 11th Asia-Pacific Conference on Human Genetics in Hanoi, Viet Nam, September 16, 2015. The pre-conference workshop provided an opportunity for medical geneticists and genetic counselors from across 10 Asia Pacific countries to learn about the varied genetic counseling practices and strategies for genetic counseling training. This paper provides an overview of the current status and challenges in these countries, and proposed course of unified actions for the future of the genetic counseling profession.
Collapse
Affiliation(s)
- Mercy Y Laurino
- Department of Pediatrics, College of Medicine, University of the Philippines Manila, Manila, Philippines.
- Cancer Prevention Program, Seattle Cancer Care Alliance, 825 Eastlake Ave East Suite 210, Seattle, WA, 98109, USA.
| | - Kathleen A Leppig
- Group Health Cooperative, Seattle, WA, USA
- Department of Pathology, University of Washington, Seattle, WA, USA
| | - Peter James Abad
- Department of Pediatrics, College of Medicine, University of the Philippines Manila, Manila, Philippines
- College of Nursing, University of the Philippines Manila, Manila, Philippines
| | - Breana Cham
- Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore
| | - Yoyo Wing Yiu Chu
- Department of Pediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, SAR, China
| | - Saahil Kejriwal
- Institute for Public Health Genetics, University of Washington, Seattle, WA, USA
- Strand Life Sciences, Bengaluru, India
| | - Juliana M H Lee
- Asia Genomics Pte Ltd, Kuala Lumpur, Malaysia
- Genetic Counseling Asia, Kuala Lumpur, Malaysia
| | - Darci L Sternen
- Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA
| | | | - Matthew J Burgess
- Clinical Genetics Service, Austin Health, Heidelberg, VIC, Australia
| | - Shu Chien
- Genetic Consultation Center, Taichung Veterans General Hospital, Taichung, Taiwan
| | | | - Jiin Ying Lim
- Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore
| | - Thanyachai Sura
- Department of Medicine, Ramathibodi Hospital Medical School, Mahidol University, Bangkok, Thailand
| | - Sultana Faradz
- Master's Program in Genetic Counseling, Diponegoro University, Semarang, Indonesia
| | - Carmencita Padilla
- Department of Pediatrics, College of Medicine, University of the Philippines Manila, Manila, Philippines
- Institute of Human Genetics, National Institute of Health, University of the Philippines Manila, Manila, Philippines
| | - Eva Cutiongco de-la Paz
- Department of Pediatrics, College of Medicine, University of the Philippines Manila, Manila, Philippines
- Institute of Human Genetics, National Institute of Health, University of the Philippines Manila, Manila, Philippines
| | - Donny Nauphar
- Faculty of Medicine, Swadaya Gunung Jati University, Cirebon, Indonesia
| | | | - Olya Zayts
- School of English, The University of Hong Kong, Faculty of Arts, Hong Kong, SAR, China
| | - Dung Chi Vu
- National Hospital of Pediatrics, Hanoi, Viet Nam
| | - Meow-Keong Thong
- Department of Pediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| |
Collapse
|
3
|
Tang J, Tang CY, Wang F, Guo Y, Tang HN, Zhou CL, Tan SW, Liu SP, Zhou ZG, Zhou HD. Genetic diagnosis and treatment of a Chinese ketosis-prone MODY 3 family with depression. Diabetol Metab Syndr 2017; 9:5. [PMID: 28105082 PMCID: PMC5240193 DOI: 10.1186/s13098-016-0198-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Accepted: 12/04/2016] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND To analyze the gene mutation and mental disorder of a Chinese ketosis-prone diabetes (KPD) family, and to make a precise diagnosis and give a treatment for them. METHODS We studied a Chinese family with a clinical diagnosis of maturity-onset diabetes of the young (MODY). The clinical data and the blood samples were collected. The promotor and coding regions inclusive intron exon boundaries of the HNF1A, HNF4A were detected by polymerase chain reaction (PCR) and direct sequencing. The missense mutation was also analyzed by bioinformatics. Genetic counseling was performed twice a month to relieve the mental disorder of the persons. RESULTS The missense mutation c.779 C>T (p.T260M) in exon4 of HNF1A gene was detected, and the symptom heterogenicity among persons in this family were found. All the members were retreated with Gliclazide and stopped to use other medicine, the blood glucose of them were well controlled. We also performed an active genetic counseling to them and the mental disorder of the proband's sister was relieved. CONCLUSIONS A missense mutation of HNF1A gene was first found in Chinese ketosis-prone MODY family with manifestations heterogenicity among the persons. Sulphonylureas medicine and genetic counseling are efficiency ways to treat MODY 3 and its' mental disorder respectively.
Collapse
Affiliation(s)
- Jun Tang
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Chen-Yi Tang
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Fang Wang
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Yue Guo
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Hao-Neng Tang
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Ci-La Zhou
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Shu-Wen Tan
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Shi-Ping Liu
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Zhi-Guang Zhou
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| | - Hou-De Zhou
- Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Disease, The Second Xiang-Ya Hospital of Central South University, 139 Middle Ren-Min Road, Changsha, China
| |
Collapse
|
4
|
Pollak SJ. Correlates of genetic counseling and testing among Orthodox Jews. JOURNAL OF RELIGION AND HEALTH 2011; 50:796-805. [PMID: 19669887 DOI: 10.1007/s10943-009-9274-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/15/2009] [Accepted: 07/23/2009] [Indexed: 05/28/2023]
Abstract
One hundred and thirty-six Orthodox Jews responded to questions about their family background, disability attitudes, and their participation in genetic counseling and testing. Findings showed that only birth order and the presence of a disabled family member correlated with increased chances of an individual going for genetic counseling/testing. Results are discussed in the context of the contemporary sociology of Orthodox Judaism, with a particular focus on better understanding the experience of having a disabled family member.
Collapse
|
5
|
Ormond KE. Medical ethics for the genome world: a paper from the 2007 William Beaumont hospital symposium on molecular pathology. J Mol Diagn 2008; 10:377-82. [PMID: 18687790 PMCID: PMC2518732 DOI: 10.2353/jmoldx.2008.070162] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/14/2008] [Indexed: 11/20/2022] Open
Abstract
Medical genetics, and in particular the areas of genetic testing and genetic counseling, are replete with ethical and social issues. This review provides readers with a summary of the genetic testing and counseling process, as well as the clinical challenges that can lead to ethical dilemmas during these processes. Using a clinical medical ethics approach, several hypothetical case scenarios are presented and discussed to provide examples of the ethical issues that can arise.
Collapse
Affiliation(s)
- Kelly E Ormond
- Department of Genetics, Stanford University, Stanford, California, USA.
| |
Collapse
|
6
|
Abstract
Genetics has transformed the use of family history information and has led to the reemergence of the detailed genetic family history. It is critical that public and professional educational efforts to increase family history awareness and working knowledge are prioritized. Patient maintenance of the pedigree provides increased patient awareness and facilitates some of the limitations associated with conventional medical history ascertainment, ultimately improving health care and research. The increasing use of genetic screening promises to cultivate a paradigm shift in medical treatment emphasizing primary prevention and early intervention. Appreciation of the family history is necessary to make this important advance.
Collapse
Affiliation(s)
- Robert B Hinton
- Division of Cardiology, MLC 2003, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
| |
Collapse
|
7
|
Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, Williams JL. A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report. J Genet Couns 2006; 15:77-83. [PMID: 16761103 DOI: 10.1007/s10897-005-9014-3] [Citation(s) in RCA: 484] [Impact Index Per Article: 26.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The Genetic Counseling Definition Task Force of the National Society of Genetic Counselors (NSGC) developed the following definition of genetic counseling that was approved by the NSGC Board of Directors: Genetic counseling is the process of helping people understand and adapt to the medical, psychological and familial implications of genetic contributions to disease. This process integrates the following: Interpretation of family and medical histories to assess the chance of disease occurrence or recurrence. Education about inheritance, testing, management, prevention, resources and research. Counseling to promote informed choices and adaptation to the risk or condition. The definition was approved after a peer review process with input from the NSGC membership, genetic professional organizations, the NSGC legal counsel, and leaders of several national genetic advocacy groups.
Collapse
|
8
|
McConkie-Rosell A, Finucane B, Cronister A, Abrams L, Bennett RL, Pettersen BJ. Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors. J Genet Couns 2006; 14:249-70. [PMID: 16047089 DOI: 10.1007/s10897-005-4802-x] [Citation(s) in RCA: 86] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
These recommendations describe the minimum standard criteria for genetic counseling and testing of individuals and families with fragile X syndrome, as well as carriers and potential carriers of a fragile X mutation. The original guidelines (published in 2000) have been revised, replacing a stratified pre- and full mutation model of fragile X syndrome with one based on a continuum of gene effects across the full spectrum of FMR1 CGG trinucleotide repeat expansion. This document reviews the molecular genetics of fragile X syndrome, clinical phenotype (including the spectrum of premature ovarian failure and fragile X-associated tremor-ataxia syndrome), indications for genetic testing and interpretation of results, risks of transmission, family planning options, psychosocial issues, and references for professional and patient resources. These recommendations are the opinions of a multicenter working group of genetic counselors with expertise in fragile X syndrome genetic counseling, and they are based on clinical experience, review of pertinent English language articles, and reports of expert committees. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. The professional judgment of a health care provider, familiar with the facts and circumstances of a specific case, will always supersede these recommendations.
Collapse
|